Antibiotic agents in the elderly

Infectious Disease Clinics of North America

Volumn 18, Issue 3, 2004, Pages 533-549

  Stalam, Malini ^a,c   Kaye, Donald ^b  

^a Southeastern Veterans Center   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Audubon ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALLOPURINOL; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AMPICILLIN; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; DIGOXIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; LOOP DIURETIC AGENT; MACROLIDE; METRONIDAZOLE; MEVINOLIN; MOXIFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; SIMVASTATIN; TETRACYCLINE DERIVATIVE; THEOPHYLLINE; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN; WARFARIN;

BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BACTERIURIA; BIOPSY; CELLULITIS; CLOSTRIDIUM DIFFICILE; COMPLIANCE (PHYSICAL); DIARRHEA; DISEASE PREDISPOSITION; DRUG ABSORPTION; GROUPS BY AGE; HEARING LOSS; HEART ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MICROBIOLOGY; NEPHROTOXICITY; OTOTOXICITY; QT PROLONGATION; RASH; REVIEW; RHABDOMYOLYSIS; SEROTONIN SYNDROME; SIDE EFFECT; SOFT TISSUE INFECTION; URINARY TRACT INFECTION; VACCINATION;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG RESISTANCE, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; PNEUMONIA; SOFT TISSUE INFECTIONS; URINARY TRACT INFECTIONS;

EID: 4043100492     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2004.04.004     Document Type: Review

References (71)

1. Bentley D.W., Bradley S., High K., Schoenbaum S., Taler G., Yoshikawa T.T. Practice guideline for evaluation of fever and infection in long-term care facilities. Clin Infect Dis. 31:2000;640-653
2. Swift C.G. Pharmacokinetics and prescribing in the elderly. J Antimicrob Chemother. 34:(Suppl A):1994;25-32
3. Borrego F., Gleckman R. Principles of antibiotic prescribing in the elderly. Drugs Aging. 11:1997;7-18
4. Beers M., Avorn J., Soumerai S.B., Everitt D.E., Sherman D.S., Salem S. Psychoactive medication use in intermediate-care facility residents. JAMA. 260:1988;3016-3020
5. Claesson S., Morrison A., Wertheimer A.I., Berger M.L. Compliance with prescribed drugs: challenges for the elderly population. Pharm World Sci. 21:1999;256-259
6. Cockburn J., Gibberd R.W., Reid A.L., Sanson-Fisher R.W. Determinants of non-compliance with short term antibiotic regimens. BMJ. 295:1987;814-818
7. Cockburn J., Reid A.L., Bowman J.A., Sanson-Fisher R.W. Effects of intervention on antibiotic compliance in patients in general practice. Med J Aust. 147:1987;324-328
8. Beyth R.J., Shorr R.I. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging. 14:1999;231-239
9. Gurwitz J.H., Field T.S., Avorn J., et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 109:2000;87-94
10. Yoshikawa T.T. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis. 30:2000;931-933
11. Lieberman D., Schlaeffer F., Boldur I., et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax. 51:1996;179-184
12. Neill A.M., Martin I.R., Weir R., et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax. 51:1996;1010-1016
13. Ragnar Norrby S. Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group. J Antimicrob Chemother. 39:1997;499-508
14. Lazarus B.A., Murphy J.B., Culpepper L. Aspiration associated with long-term gastric versus jejunal feeding: a critical analysis of the literature. Arch Phys Med Rehabil. 71:1990;46-53
15. Marrie T.J., Durant H., Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis. 11:1989;586-599
16. Fang G.D., Fine M., Orloff J., et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine (Baltimore). 69:1990;307-316
17. Bates J.H., Campbell G.D., Barron A.L., et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest. 101:1992;1005-1012
18. Marston B.J., Plouffe J.F., File T.M. Jr., et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 157:1997;1709-1718
19. Scheld W.M. Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis. 9:2003;1-9
20. Gotfried M., Quinn T.C., Gothelf S., Wikler M.A., Webb C.D., Nicholson S.C. Oral gatifloxacin in outpatient community-acquired pneumonia: results from TeqCES, a community-based, open-label, multicenter study. Diagn Microbiol Infect Dis. 44:2002;85-91
21. Johnson J.R. Doxycycline for treatment of community-acquired pneumonia. Clin Infect Dis. 35:2002;632. [author reply: 632-3]
22. Mandell L.A., Bartlett J.G., Dowell S.F., File T.M. Jr., Musher D.M., Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 37:2003;1405-1433
23. Doern G.V., Pfaller M.A., Kugler K., Freeman J., Jones R.N. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis. Oct. 27:(4):1998;764-770
24. Jacobs M.R., Bajaksouzian S., Zilles A., Lin G., Pankuch G.A., Appelbaum P.C. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US Surveillance study. Antimicrob Agents Chemother. 43:1999;1901-1908
25. Thornsberry C., Sahm D.F., Kelly L.J., et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000. Clin Infect Dis. 34:(Suppl 1):2002;S4-S16
26. Fogarty C.M., Cyganowski M., Palo W.A., Hom R.C., Craig W.A. A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study. Clin Ther. 24:2002;1854-1870
27. van Zyl L., le Roux J.G., LaFata J.A., et al. Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study. Clin Ther. 24:2002;1840-1853
28. Bartlett J.G., Breiman R.F., Mandell L.A., File T.M. Jr. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis. 26:1998;811-838
29. Gudiol F., Manresa F., Pallares R., et al. Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med. 150:1990;2525-2529
30. Visalli M.A., Jacobs M.R., Appelbaum P.C. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. Antimicrob Agents Chemother. 41:1997;1867-1870
31. Gleason P.P., Meehan T.P., Fine J.M., Galusha D.H., Fine M.J. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med. 159:1999;2562-2572
32. Niederman M.S., Mandell L.A., Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 163:2001;1730-1754
33. Craven D.E., Kunches L.M., Kilinsky V., Lichtenberg D.A., Make B.J., McCabe W.R. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis. 133:1986;792-796
34. Gross P.A., Neu H.C., Aswapokee P., Van Antwerpen C., Aswapokee N. Deaths from nosocomial infections: experience in a university hospital and a community hospital. Am J Med. 68:1980;219-223
35. McEachern R., Campbell G.D. Jr. Hospital-acquired pneumonia: epidemiology, etiology, and treatment. Infect Dis Clin North Am. 12:1998;761-779
36. Chastre J., Wolff M., Fagon J.Y., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 290:2003;2588-2598
37. Yoshikawa T.T. Antimicrobial resistance and aging: beginning of the end of the antibiotic era? J Am Geriatr Soc. 50:(Suppl 7):2002;S226-S229
38. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med. 123:1995;518-527
39. Shapiro E.D., Berg A.T., Austrian R., et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 325:1991;1453-1460
40. Sims R.V., Steinmann W.C., McConville J.H., King L.R., Zwick W.C., Schwartz J.S. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med. 108:1988;653-657
41. Snow R., Babish J.D., McBean A.M. Is there any connection between a second pneumonia shot and hospitalization among Medicare beneficiaries? Public Health Rep. 110:1995;720-725
42. Yoshikawa T.T., Nicolle L.E., Norman D.C. Management of complicated urinary tract infection in older patients. J Am Geriatr Soc. 44:1996;1235-1241
43. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Dolin R, editors. Principles and practice of infectious diseases. 6th edition. Philadelphia: Churchill Livingstone, in press.
44. Nicolle L.E. Urinary tract infections in long-term-care facilities. Infect Control Hosp Epidemiol. 22:2001;167-175
45. Baldassarre J.S., Kaye D. Special problems of urinary tract infection in the elderly. Med Clin North Am. 75:1991;375-390
46. Nicolle L.E., Bjornson J., Harding G.K., MacDonell J.A. Bacteriuria in elderly institutionalized men. N Engl J Med. 309:1983;1420-1425
47. Warren J.W. Catheter-associated bacteriuria. Clin Geriatr Med. 8:1992;805-819
48. Johnson J.R., Stamm W.E. Urinary tract infections in women: diagnosis and treatment. Ann Intern Med. 111:1989;906-917
49. Lipsky B.A. Urinary tract infections in men: epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med. 110:1989;138-150
50. Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am. 17:2003;243-259
51. Harding G.K., Zhanel G.G., Nicolle L.E., Cheang M. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med. 347:2002;1576-1583
52. Nicolle L.E. Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am. 11:1997;647-662
53. Sobel J.D., Kauffman C.A., McKinsey D., et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis. 30:2000;19-24
54. Stotts N.A., Hunt T.K. Pressure ulcers: managing bacterial colonization and infection. Clin Geriatr Med. 13:1997;565-573
55. Pacio G.A., Visintainer P., Maguire G., Wormser G.P., Raffalli J., Montecalvo M.A. Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Infect Control Hosp Epidemiol. 24:2003;246-250
56. Lewis V.L. Jr., Bailey M.H., Pulawski G., Kind G., Bashioum R.W., Hendrix R.W. The diagnosis of osteomyelitis in patients with pressure sores. Plast Reconstr Surg. 81:1988;229-232
57. Ehrenkranz N.J., Alfonso B., Nerenberg D. Irrigation-aspiration for culturing draining decubitus ulcers: correlation of bacteriological findings with a clinical inflammatory scoring index. J Clin Microbiol. 28:1990;2389-2393
58. Sugarman B., Hawes S., Musher D.M., Klima M., Young E.J., Pircher F. Osteomyelitis beneath pressure sores. Arch Intern Med. 143:1983;683-688
59. Patterson J.A., Bennett R.G. Prevention and treatment of pressure sores. J Am Geriatr Soc. 43:1995;919-927
60. Bryan C.S., Dew C.E., Reynolds K.L. Bacteremia associated with decubitus ulcers. Arch Intern Med. 143:1983;2093-2095
61. Nicolle L.E., Strausbaugh L.J., Garibaldi R.A. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev. 9:1996;1-17
62. Kyne L., Merry C., O'Connell B., Kelly A., Keane C., O'Neill D. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing. 28:1999;107-113
63. Simor A.E., Yake S.L., Tsimidis K. Infection due to Clostridium difficile among elderly residents of a long-term-care facility. Clin Infect Dis. 17:1993;672-678
64. Sims R.V., Hauser R.J., Adewale A.O., et al. Acute gastroenteritis in three community-based nursing homes. J Gerontol A Biol Sci Med Sci. 50:1995;M252-M256
65. Karlstrom O., Fryklund B., Tullus K., Burman L.G. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis. 26:1998;141-145
66. Simor A.E., Bradley S.F., Strausbaugh L.J., Crossley K., Nicolle L.E. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol. 23:2002;696-703
67. Strausbaugh L.J., Crossley K.B., Nurse B.A., Thrupp L.D. Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol. 17:1996;129-140
68. Mayfield J.L., Leet T., Miller J., Mundy L.M. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 31:2000;995-1000
69. Muder R.R., Brennen C., Wagener M.M., et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med. 114:1991;107-112
70. Brennen C., Wagener M.M., Muder R.R. Vancomycin-resistant Enterococcus faecium in a long-term care facility. J Am Geriatr Soc. 46:1998;157-160
71. Elizaga M.L., Weinstein R.A., Hayden M.K. Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. Clin Infect Dis. 34:2002;441-446